These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10718366)

  • 41. A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium.
    Miyagiwa M; Ichida T; Tokiwa T; Sato J; Sasaki H
    In Vitro Cell Dev Biol; 1989 Jun; 25(6):503-10. PubMed ID: 2544546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of cholecystokinin on human cholangiocarcinoma xenografted into nude mice.
    Hudd C; Euhus DM; LaRegina MC; Herbold DR; Palmer DC; Johnson FE
    Cancer Res; 1985 Mar; 45(3):1372-7. PubMed ID: 2982488
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Establishment and characterization of a CA19-9 producing human gastric cancer cell line, STKM-1].
    Arimura A; Nakamura Y; Shimizu A; Harada M; Yanoma S
    Hum Cell; 1991 Mar; 4(1):67-70. PubMed ID: 1888706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishment and characterization of a new human lung poorly differentiated adenocarcinoma cell line, GLL-1, producing carcinoembryonic antigen (CEA) and CA19-9.
    Mitsuhashi N; Takahashi T; Sakurai H; Yamakawa M; Hasegawa M; Furuta M; Matsumoto H; Higuchi K; Hayakawa K; Niibe H
    Lung Cancer; 1995 Mar; 12(1-2):13-24. PubMed ID: 7600027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
    Tanaka S; Iwai M; Harada Y; Morikawa T; Muramatsu A; Mori T; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
    Cancer Gene Ther; 2000 Sep; 7(9):1241-50. PubMed ID: 11023196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization and genetic analysis in the newly established human bile duct cancer cell lines.
    Ghosh M; Koike N; Tsunoda S; Hirano T; Kaul S; Kashiwagi H; Kawamoto T; Ohkohchi N; Saijo K; Ohno T; Miwa M; Todoroki T
    Int J Oncol; 2005 Feb; 26(2):449-56. PubMed ID: 15645130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma.
    Tokunaga R; Imamura Y; Nakamura K; Uchihara T; Ishimoto T; Nakagawa S; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Oyama S; Shono T; Naoe H; Saeki H; Oki E; Watanabe M; Sasaki Y; Maehara Y; Baba H
    Cancer Med; 2015 Nov; 4(11):1659-66. PubMed ID: 26310928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Tumor Markers and Their Impact on Prognosis in Gallbladder, Bile Duct and Cholangiocellular Carcinomas - A Pilot Study.
    Liska V; Treska V; Skalicky T; Fichtl J; Bruha J; Vycital O; Topolcan O; Palek R; Rosendorf J; Polivka J; Holubec L
    Anticancer Res; 2017 Apr; 37(4):2003-2009. PubMed ID: 28373474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comment on: isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.
    Gradilone A; Gazzaniga P; Raimondi C; Aglianò AM; Frati L
    Int J Cancer; 2011 Apr; 128(8):1997-8. PubMed ID: 20568108
    [No Abstract]   [Full Text] [Related]  

  • 50. [Immunohistochemical analysis for cholangiocarcinoma].
    Nakagoe T; Matsuo T; Kondoh M; Yamaguchi H
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():370-4. PubMed ID: 16457285
    [No Abstract]   [Full Text] [Related]  

  • 51. [A case of transitional cell carcinoma of the renal pelvis with adenocarcinoma producing CEA and CA19-9].
    Matsuoka Y; Ishimaru H; Arai G; Aida J; Okada Y; Ito Y
    Hinyokika Kiyo; 2004 Sep; 50(9):637-40. PubMed ID: 15518131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (KMBC).
    Yano H; Maruiwa M; Iemura A; Mizoguchi A; Kojiro M
    Cancer; 1992 Apr; 69(7):1664-73. PubMed ID: 1312890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (ICBD-1).
    Takiyama I; Terashima M; Ikeda K; Kawamura H; Kashiwaba M; Tamura G; Suto T; Nakashima F; Sasaki R; Saito K
    Oncol Rep; 1998; 5(2):463-7. PubMed ID: 9468580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
    Ozkan H; Kaya M; Cengiz A
    Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated perioperative serum CA 19-9 levels are independent predictors of poor survival in patients with resectable cholangiocarcinoma.
    Kondo N; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Sasaki H; Sueda T
    J Surg Oncol; 2014 Sep; 110(4):422-9. PubMed ID: 24889968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression and antitumor effects of TRAIL in human cholangiocarcinoma.
    Tanaka S; Sugimachi K; Shirabe K; Shimada M; Wands JR
    Hepatology; 2000 Sep; 32(3):523-7. PubMed ID: 10960444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Establishment and characterization of a new poorly differentiated gastric cancer cell line (MKK-1), derived from Borrmann type 3 tumor].
    Ihara A
    Nihon Shokakibyo Gakkai Zasshi; 1992 Nov; 89(11):2645-54. PubMed ID: 1460764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.